1. Home
  2. LGN vs NVST Comparison

LGN vs NVST Comparison

Compare LGN & NVST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LGN
  • NVST
  • Stock Information
  • Founded
  • LGN 1963
  • NVST 2018
  • Country
  • LGN United States
  • NVST United States
  • Employees
  • LGN N/A
  • NVST N/A
  • Industry
  • LGN
  • NVST Medical/Dental Instruments
  • Sector
  • LGN
  • NVST Health Care
  • Exchange
  • LGN Nasdaq
  • NVST Nasdaq
  • Market Cap
  • LGN 3.1B
  • NVST 3.4B
  • IPO Year
  • LGN 2025
  • NVST 2019
  • Fundamental
  • Price
  • LGN $31.67
  • NVST $20.84
  • Analyst Decision
  • LGN
  • NVST Buy
  • Analyst Count
  • LGN 0
  • NVST 12
  • Target Price
  • LGN N/A
  • NVST $20.91
  • AVG Volume (30 Days)
  • LGN 1.8M
  • NVST 1.9M
  • Earning Date
  • LGN 01-01-0001
  • NVST 10-30-2025
  • Dividend Yield
  • LGN N/A
  • NVST N/A
  • EPS Growth
  • LGN N/A
  • NVST N/A
  • EPS
  • LGN N/A
  • NVST 0.31
  • Revenue
  • LGN $2,213,862,000.00
  • NVST $2,552,900,000.00
  • Revenue This Year
  • LGN N/A
  • NVST $6.55
  • Revenue Next Year
  • LGN N/A
  • NVST $3.33
  • P/E Ratio
  • LGN N/A
  • NVST $66.85
  • Revenue Growth
  • LGN 77.61
  • NVST 0.76
  • 52 Week Low
  • LGN $26.96
  • NVST $14.22
  • 52 Week High
  • LGN $34.40
  • NVST $23.00
  • Technical
  • Relative Strength Index (RSI)
  • LGN N/A
  • NVST 52.43
  • Support Level
  • LGN N/A
  • NVST $19.80
  • Resistance Level
  • LGN N/A
  • NVST $20.45
  • Average True Range (ATR)
  • LGN 0.00
  • NVST 0.54
  • MACD
  • LGN 0.00
  • NVST -0.03
  • Stochastic Oscillator
  • LGN 0.00
  • NVST 56.56

About NVST Envista Holdings Corporation

Envista Holdings Corp is a dental products company. It develops, manufactures, and markets portfolios of dental consumables, equipment, and services to dental professionals. The company's business consists of two segments; Specialty Products & Technologies and Equipment & Consumables. The company's Specialty Products & Technologies segment, which derives key revenue, develops, manufactures, and markets dental implant systems, including regenerative solutions, dental prosthetics, and associated treatment software and technologies, as well as orthodontic bracket systems, aligners, and lab products. Geographically, the company generates a majority of its revenue from North America, followed by Western Europe and other developed and emerging markets.

Share on Social Networks: